Provides the latest RSS feeds for Pharmaceutical News. For more headlines on Breaking, National, Business, Finance, Sports and World News, visit our home page industriesnews.net http://www.industriesnews.net/pharmaceutical/&cid=39 en-us Fri, 24 May 2013 14:16:03 -0400 Fri, 24 May 2013 14:16:03 -0400 30 DUBLIN/ WASHINGTON Ireland-based biotechnology firm Elan Thursday rejected Royalty Pharma's increased $6.4 billion takeover bid, shortly after the U.S. firm cut the acceptance bar for its latest offer to 50 percent plus one share. Royalty raised its hostile cash bid to $12.50 per share on Monday, from $11.25 previously, but made the new offer conditional on Elan shareholders rejecting, at a ... http://www.industriesnews.net/story?sid=s214724870&cid=39 Thu, 23 May 2013 17:52:46 -0400 http://www.industriesnews.net/story?sid=s214724870 MUMBAI - Shares of Wockhardt, one of the leading Indian pharmaceutical and biotechnology companies, witnessed a sharp fall of 20% to Rs. 1,315 ($23.61) on the Bombay Stock Exchange(BSE) on Thursday after the US FDA published an import alert on one of its three manufacturing facilities near Aurangabad. The import alert, 'detention without physical examination of drugs from firms which have ... http://www.industriesnews.net/story?sid=s214722664&cid=39 Thu, 23 May 2013 16:26:11 -0400 http://www.industriesnews.net/story?sid=s214722664 With its enclosed design, the FrymaKoruma Frymix II vacuum processing unit is the system of choice for manufacturers of high-quality pharmaceuticals. The machine complies with all cGMP/GAMP specifications for sterile suspensions and emulsions. The products are processed utilizing the rotor-rotor principle by a powerful homogenizer, which was explicitly developed for temperature and ... http://www.industriesnews.net/story?sid=s214742346&cid=39 Fri, 24 May 2013 13:06:30 -0400 PharmPro http://www.industriesnews.net/story?sid=s214742346 Model ZW400 oil-less air compressor offers OEM Engineers a viable option for applications in the medical and lab markets. With high flow output, the most demanding design specifications will be covered. Structural parts are aluminum, providing a lightweight yet robust assembly. Valve and electrical components are balanced for smooth, quiet operation. The ZW400 provides a versatile long life ... http://www.industriesnews.net/story?sid=s214742347&cid=39 Fri, 24 May 2013 13:06:29 -0400 PharmPro http://www.industriesnews.net/story?sid=s214742347 (WBIR- Bean Station, Tenn.) A former police officer has been charged overnight with a shooting spree inside a local drugstore that left two men dead and two women injured. The shooting happened at the Down Home pharmacy in Bean Station around 11:15 am on Thursday. According to District Attorney General Jimmy Dunn, Jason Brian Holt, 37, was arrested shortly after the shooting. According to ... http://www.industriesnews.net/story?sid=s214740268&cid=39 Fri, 24 May 2013 11:57:47 -0400 WBIR http://www.industriesnews.net/story?sid=s214740268 Merrimack Pharmaceuticals has completed patient enrollment in a Phase 2 study evaluating the efficacy of MM-121 in combination with exemestane compared to exemestane alone in breast cancer. Postmenopausal women with locally advanced or metastatic estrogen receptor positive (ER+) and/or progesterone receptor positive (PR+), HER2-negative breast cancer are participating in the randomized, double ... http://www.industriesnews.net/story?sid=s214740269&cid=39 Fri, 24 May 2013 11:51:04 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214740269 Pharmaceutical and medical-device maker Nordion has signed an agreement to sell its Targeted Therapies business to international specialist healthcare company, BTG, for $200m in cash. As per terms of the deal, BTG is expected to gain TheraSphere, which is the sole targeted liver cancer therapy product of Targeted Therapies business that is manufactured and commercialized by Nordion. Nordion has ... http://www.industriesnews.net/story?sid=s214740270&cid=39 Fri, 24 May 2013 11:51:03 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214740270 Umecrine Mood, part of the Karolinska Development portfolio, has commenced dosing in the Phase I/II study of UC1010 for premenstrual dysphoric disorder (PMDD). A total of 120 individuals are expected to be included in the double-blind, multicenter study designed to assess the safety and efficacy profile of UC1010. Umecrine Mood CEO Karin Ekberg said it is the first company to develop compounds ... http://www.industriesnews.net/story?sid=s214740271&cid=39 Fri, 24 May 2013 11:51:02 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214740271 Celgene International has obtained FDA priority review status for Abraxane (paclitaxel protein-bound particles for injectable suspension) supplemental new drug application (sNDA). The application covers the use of Abraxane and gemcitabine combination therapy for the front line treatment of patients with advanced pancreatic cancer. In April 2013, the European Medicines Agency also accepted ... http://www.industriesnews.net/story?sid=s214740272&cid=39 Fri, 24 May 2013 11:51:01 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214740272 The China State and Food Administration (CFDA) has granted the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) to Sinovac Beijing under the new GMP guidelines. The certificate is granted for the company's proprietary vaccines, Haidian district bulk production plants, and Changping filing and packaging facility. Sinovac chairman, president and CEO ... http://www.industriesnews.net/story?sid=s214740273&cid=39 Fri, 24 May 2013 11:51:00 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214740273 Howard University College of Pharmacy and US-based immunotherapies developer TNI BioTech have signed a multi-year deal to develop new drugs in Africa. Under the partnership, the college will support the development of new and commercial delivery forms of low dose Naltrexone in the form of oral capsules and tablets and topical creams, apart from developing commercial forms of Met-Enkephalin ... http://www.industriesnews.net/story?sid=s214740274&cid=39 Fri, 24 May 2013 11:51:00 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214740274 More than 40 million Americans don't get enough sleep, according to the Centers for Disease Control and Prevention. And what they're doing about it might not be so helpful either. MarketWatch's Jim Jelter discusses five things the sleep-aid industry won't ... http://www.industriesnews.net/story?sid=s214740275&cid=39 Fri, 24 May 2013 11:50:59 -0400 PharmPro http://www.industriesnews.net/story?sid=s214740275 MedVantx, a provider of consumer medication management and delivery services, has completed expansion of its home delivery platform to manage $1.5bn in prescription medications. The company has also upgraded its systems to provide current good manufacturer practices (cGMP)-level quality in its home delivery pharmacy in Sioux Falls, South Dakota to prevent deviations, failures and errors. ... http://www.industriesnews.net/story?sid=s214740277&cid=39 Fri, 24 May 2013 11:50:59 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214740277 The Cobas Integra 800 is a blood test that measures a patient's average blood sugar level over the previous three months. In particular, the test measures an oxygen-carrying blood component known as ... http://www.industriesnews.net/story?sid=s214740278&cid=39 Fri, 24 May 2013 11:50:58 -0400 PharmPro http://www.industriesnews.net/story?sid=s214740278 Studies show up to 15 percent of women between the ages of 20 and 60 have a sexual desire disorder. This interview with relationship experts Ian Kernerand Logan Levkoff discusses the new drugs being developed to help women with sexual ... http://www.industriesnews.net/story?sid=s214740276&cid=39 Fri, 24 May 2013 11:50:58 -0400 PharmPro http://www.industriesnews.net/story?sid=s214740276 NEW YORK (AP) -- Shares of Forest Laboratories Inc. rose to a year high Thursday after the drugmaker said Howard Solomon, its CEO for 36 years, will retire at the end of ... http://www.industriesnews.net/story?sid=s214740279&cid=39 Fri, 24 May 2013 11:50:57 -0400 PharmPro http://www.industriesnews.net/story?sid=s214740279 Astellas Pharma Inc. (TOKYO: 4503) and Medivation, Inc. (NASDAQ: MDVN) today announced that Astellas has submitted an application for marketing approval of enzalutamide (generic name) to the Ministry of Health, Labour and Welfare in Japan for the treatment ... http://www.industriesnews.net/story?sid=s214740282&cid=39 Fri, 24 May 2013 11:49:49 -0400 News-Medical http://www.industriesnews.net/story?sid=s214740282 Norgine today announced that the Australian assessment body the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the use of XIFAXAN 550 mg in the prevention of the recurrence of hepatic encephalopathy (HE) where other treatments have failed or are contraindicated; a potentially life-threatening neuropsychiatric condition associated ... http://www.industriesnews.net/story?sid=s214740280&cid=39 Fri, 24 May 2013 11:49:49 -0400 News-Medical http://www.industriesnews.net/story?sid=s214740280 Derek Green was working the produce aisle of the Holt's IGA Market Thursday afternoon when his manager told him there had been a shooting next door. Police cars flooded the parking the lot the grocery store shared with its next-door neighbor, Down Home Pharmacy. Green watched as two women were brought out on stretchers and waited for a familiar face. His uncle, Steve Lovell, was the owner ... http://www.industriesnews.net/story?sid=s214733347&cid=39 Fri, 24 May 2013 05:19:07 -0400 WBIR http://www.industriesnews.net/story?sid=s214733347 Servier and miRagen Therapeutics have announced the selection of a third target under the agreement aimed at advancing the research and commercialization of microRNA-based drug candidates against cardiovascular diseases. Selection of the third cardiovascular target by Servier marks the first milestone for miRagen under the collaboration. Servier chief executive officer Dr. Jean-Philippe Seta ... http://www.industriesnews.net/story?sid=s214733348&cid=39 Fri, 24 May 2013 05:12:17 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214733348 Johnson & Johnson's Pharmaceuticals unit Janssen is planning to submit more than 10 new products for regulatory approval and extend the brand pipeline of 25 existing drugs by 2017. The late stage products to be submitted for approval include drugs targeting varying diseases such as hepatitis C, immune diseases and schizophrenia, and vaccines for flu, rabies and polio. Johnson & ... http://www.industriesnews.net/story?sid=s214733349&cid=39 Fri, 24 May 2013 05:12:15 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214733349 Smartphone solutions for clinical trials: an interview with Dr. Anthony Sterns, CEO, iRx Reminder and Napoleon Monroe, Managing Director, New Directions Technology ... http://www.industriesnews.net/story?sid=s214733351&cid=39 Fri, 24 May 2013 05:11:09 -0400 News-Medical http://www.industriesnews.net/story?sid=s214733351 RNA to synthesize B cyclin ", Dr. Michnick explained. "We also found that TOR acts through a previously unforeseen intermediary, a protein that makes small chemical modifications to proteins normally stabilize B cyclin ", he added. "We have known that starvation and a drug that mimics starvation, rapamycin, affects B cyclin synthesis, but we didn't know how. Our studies ... http://www.industriesnews.net/story?sid=s214733350&cid=39 Fri, 24 May 2013 05:11:09 -0400 News-Medical http://www.industriesnews.net/story?sid=s214733350 On Capitol Hill, several legislative efforts are moving forward on health issues. Among them is an effort by the Massachusetts delegation to keep bonus Medicare payments for the state's hospitals, while House Republicans are looking for another way to deal with a bill to fund high-risk insurance ... http://www.industriesnews.net/story?sid=s214733352&cid=39 Fri, 24 May 2013 05:11:08 -0400 News-Medical http://www.industriesnews.net/story?sid=s214733352 Approximately a year ago, the leading journal Science published an article about bexarotene as a potential Alzheimer's drug. A significant breakthrough and an important starting point for further Alzheimer's research. The research group of Bart De Strooper - Alzheimer's researcher at VIB and KU Leuven - in collaboration with the group of Rudi D'Hooge - KU Leuven - and ... http://www.industriesnews.net/story?sid=s214733353&cid=39 Fri, 24 May 2013 05:11:08 -0400 News-Medical http://www.industriesnews.net/story?sid=s214733353 brain that are implicated in determining the value of actions, in planning actions and in motivation. Dr. Alain Dagher, from McGill University, suggests abnormal interactions between these decision-making brain regions could underlie addiction. These results were presented at the 2013 Canadian Neuroscience Meeting, the annual meeting of the Canadian Association for Neuroscience - Association ... http://www.industriesnews.net/story?sid=s214733354&cid=39 Fri, 24 May 2013 05:11:07 -0400 News-Medical http://www.industriesnews.net/story?sid=s214733354 A Connecticut-based organization is offering a $2,500 reward for information leading to the arrest of a man who reportedly robbed a Monessen pharmacy of prescription painkillers on April ... http://www.industriesnews.net/story?sid=s214731217&cid=39 Fri, 24 May 2013 01:23:48 -0400 Tribune Review http://www.industriesnews.net/story?sid=s214731217 WHITEHOUSE STATION, N.J. - Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working. Merck says it reviewed initial data from three late-stage clinical trials and did not find evidence preladenant was more effective than a placebo. The company says it doesn't plan to file for marketing approval of the drug. It says ... http://www.industriesnews.net/story?sid=s214725715&cid=39 Thu, 23 May 2013 18:48:59 -0400 Star Tribune http://www.industriesnews.net/story?sid=s214725715 GENEVA (AP) -- International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the head of the World Health Organization warned ... http://www.industriesnews.net/story?sid=s214725969&cid=39 Thu, 23 May 2013 18:06:35 -0400 Tampa Bay Online http://www.industriesnews.net/story?sid=s214725969 BIG PLANS: Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones.BIG IMPACT: Two experimental medicines could transform current treatments. One is an antidepressant that appears to work in just a day, instead of taking weeks. The other is a powerful painkiller that's not addictive.BIG REBOUND: ... http://www.industriesnews.net/story?sid=s214724398&cid=39 Thu, 23 May 2013 17:31:17 -0400 Miami Herald http://www.industriesnews.net/story?sid=s214724398 An Edison, N.J. fitness trainer was charged with conspiracy to distribute anabolic steroids across the country through Internet sales, a court complaint said. Richard Gray, 60, who pleaded guilty in 2008 to similar charges, said little in his preliminary hearing in federal court in Newark Wednesday, the (Newark, N.J.) Star-Ledger reported. Gray's arrest came after agents from U.S. Customs ... http://www.industriesnews.net/story?sid=s214723028&cid=39 Thu, 23 May 2013 15:42:27 -0400 Middle East Times http://www.industriesnews.net/story?sid=s214723028 NASD: REGN ) shares, but tentative about paying the going market price of $256.05/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $165 strike, which has a bid at the time of this writing of $16.10. Collecting that bid as the premium represents a 9.8% return against the ... http://www.industriesnews.net/story?sid=s214721332&cid=39 Thu, 23 May 2013 14:56:00 -0400 Forbes http://www.industriesnews.net/story?sid=s214721332 It occurred at the Down Home Pharmacy, 1034 Main St., Bean Station, according to a Bean Station dispatcher, who did not have the time of the ... http://www.industriesnews.net/story?sid=s214719691&cid=39 Thu, 23 May 2013 13:41:11 -0400 Knox News http://www.industriesnews.net/story?sid=s214719691 DENVER-In the most prominent challenge of its kind, Hobby Lobby Stores Inc. is asking a federal appeals court Thursday for an exemption from part of the federal health care law that requires it to offer employees health coverage that includes access to the morning-after pill. The Oklahoma City-based arts-and-crafts chain argues that businesses-not just the currently exempted religious ... http://www.industriesnews.net/story?sid=s214717192&cid=39 Thu, 23 May 2013 10:59:48 -0400 Denver Post http://www.industriesnews.net/story?sid=s214717192 Davonte Hubbard was arrested Tuesday on a preliminary charge of armed robbery. Devan Twitchell was arrested Wednesday on a preliminary charge of aiding in the armed robbery. During the investigation, police say a third suspect, Hayden Glass, died of an overdose the day after the robbery. According to a release, around 10:20 a.m. May 16, two male suspects entered Henderson Pharmacy, 100 E. ... http://www.industriesnews.net/story?sid=s214716513&cid=39 Thu, 23 May 2013 10:54:06 -0400 WISH TV8 http://www.industriesnews.net/story?sid=s214716513 At a meeting today with industry analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced they anticipate submitting more than 10 new product filings and more than 25 significant brand line extensions by ... http://www.industriesnews.net/story?sid=s214715070&cid=39 Thu, 23 May 2013 10:01:23 -0400 PharmPro http://www.industriesnews.net/story?sid=s214715070 Jeunesse Global®, a network marketing company that dedicates its research to promoting healthy and youthful living, has produced the solution to one of the fundamental causes of cellular aging. Announcing a revolutionary development in anti-aging and science called FINITI™: a dietary supplement based on Nobel Prize winning research. To appreciate the importance of this ... http://www.industriesnews.net/story?sid=s214715072&cid=39 Thu, 23 May 2013 10:00:22 -0400 News-Medical http://www.industriesnews.net/story?sid=s214715072 Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, ... http://www.industriesnews.net/story?sid=s214715071&cid=39 Thu, 23 May 2013 10:00:22 -0400 News-Medical http://www.industriesnews.net/story?sid=s214715071 A new study finds that women taking 1,000 milligrams of calcium a day have a lower risk of dying, contradicting previous studied linking calcium to an increased risk of heart attacks. Dr. Holly Phillips ... http://www.industriesnews.net/story?sid=s214715160&cid=39 Thu, 23 May 2013 09:34:28 -0400 CBS News http://www.industriesnews.net/story?sid=s214715160 Biogen Idec today announced that Spyros Artavanis-Tsakonas, Ph.D., has been named the company's Chief Scientific Officer (CSO). Dr. Artavanis-Tsakonas had served as interim CSO while on sabbatical from Harvard Medical School. He will now continue in this role in a permanent capacity, and will also lead the company's research strategy, capabilities and discovery platforms. Dr. ... http://www.industriesnews.net/story?sid=s214713700&cid=39 Thu, 23 May 2013 08:48:53 -0400 PharmPro http://www.industriesnews.net/story?sid=s214713700 NEW YORK (AP) -- Royalty Pharma has eased one of its conditions for completing its recently increased offer to buy Irish drugmaker Elan Corp. PLC for $12.50 per share, or about $7.5 ... http://www.industriesnews.net/story?sid=s214713699&cid=39 Thu, 23 May 2013 08:48:52 -0400 PharmPro http://www.industriesnews.net/story?sid=s214713699 Duchesnay USA has announced the availability of Diclegis, a composition of 10mg doxylamine succinate and 10mg pyridoxine hydrochloride (vitamin B6), in US pharmacies. The FDA had approved Diclegis as the only treatment for nausea and vomiting of pregnancy (NVP) when conservative management fails. Duchesnay USA chief executive officer Gilbert Godin said Diclegis will become an treatment option ... http://www.industriesnews.net/story?sid=s214713701&cid=39 Thu, 23 May 2013 08:48:51 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214713701 Moody's Investors Service on Wednesday placed Hospira Inc.'s "Baa3" long-term debt rating under review for possible downgrade. The ratings agency said the move was based on a concern that the drug and medical device maker's performance over the next few years remains uncertain as a result of costs related to its new product strategy and possible regulatory issues. ... http://www.industriesnews.net/story?sid=s214713702&cid=39 Thu, 23 May 2013 08:48:50 -0400 PharmPro http://www.industriesnews.net/story?sid=s214713702 The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus. Details of the transaction have not been revealed, however, it is expected that the 725,000ft property would be handed over by Merck on 28 June 2013. The consortium behind the Campus Biotech initiative include the Ecole Polytechnique Fdrale de Lausanne (EPFL), the University ... http://www.industriesnews.net/story?sid=s214713703&cid=39 Thu, 23 May 2013 08:48:49 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214713703 Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug Application (IND) to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an enzyme expressed in areas of ... http://www.industriesnews.net/story?sid=s214713705&cid=39 Thu, 23 May 2013 08:47:48 -0400 News-Medical http://www.industriesnews.net/story?sid=s214713705 Celgene International Sarl, a subsidiary of Celgene Corporation (Celgene) (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) for the use of ... http://www.industriesnews.net/story?sid=s214713704&cid=39 Thu, 23 May 2013 08:47:47 -0400 News-Medical http://www.industriesnews.net/story?sid=s214713704 calcium supplement of up to 1,000 mg per day can help women live longer, according to a study whose lead author was Lisa Langsetmo, a Ph.D. Research Associate at McGill University, and whose senior author was Prof. David Goltzman, Division ... http://www.industriesnews.net/story?sid=s214713707&cid=39 Thu, 23 May 2013 08:47:46 -0400 News-Medical http://www.industriesnews.net/story?sid=s214713707 lung cancer , and in laboratory and animal tests it appears to reduce the systemic damage done to other organs while significantly improving the treatment of lung tumors. This advance in nanomedicine combines the extraordinarily small size ... http://www.industriesnews.net/story?sid=s214713706&cid=39 Thu, 23 May 2013 08:47:46 -0400 News-Medical http://www.industriesnews.net/story?sid=s214713706 Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax. The patent claims describe methods of preparing an immunologically-active adjuvant-bound, thermostable, freeze dried vaccine composition that uses conventional adjuvants comprised of aluminum salts, in addition to claims covering the adjuvant-bound composition ... http://www.industriesnews.net/story?sid=s214712395&cid=39 Thu, 23 May 2013 07:38:45 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214712395 The FDA has approved R-Tech Ueno's novel ophthalmic solution, developed using Novozymes Biopharma's recombinant human albumin, to enter into Phase I/II ... http://www.industriesnews.net/story?sid=s214712394&cid=39 Thu, 23 May 2013 07:38:44 -0400 Pharmaceutical Business Review http://www.industriesnews.net/story?sid=s214712394